At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 19 enrolled
Drug / intervention
Ankylos Implants +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in the Anterior Part of the Mandible and Restored With Fixed Prostheses: a Randomized, Split-mouth, Masked, Prospective, Open, Comparison, Monocenter Trial
In Brief
A Phase 4 clinical trial evaluating Ankylos Implants and Biomet 3i Prevail Implants for Edentulism. Completed, enrolled 19 participants across 1 site.
Detailed Summary
Change in crestal bone level implants at 5% significance level.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEdentulism
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedOct 2008
Primary CompletionApr 2012
TodayJul 2026
First PostedOct 27, 2008
Enrollment StartSep 1, 2008
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 17.7 years ago
Interventions
Ankylos Implantsdevice
ANKYLOS Implant System vs Certain PREVAIL Implant
Biomet 3i Prevail Implantsdevice